Article Details
Retrieved on: 2022-09-19 09:13:35
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Biopharma company Antengene Corporation Limited says ATG-101, the company's in-house developed novel PD-L1/4-1BB bispecific antibody, ...
Article found on: www.labiotech.eu
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here